Aim: The aim of this study was to evaluate the hepatoprotective and antioxidant activities of Ferulago angulata Extract (FAE) in experimental diabetic rats. Materials and Methods: 54 adult male Wistar rats divided into 6 groups (n=9). Diabetes was induced in all animals except those in group 1 by the daily intraperitoneal injection of 120 mg/kg Mousavi-Ezmareh et al.; EJMP, 20(2): 1-9, 2017; Article no.EJMP.35134 2 alloxan monohydrate for 3 consecutive days. Experimental diabetic rats in groups 3-5 were orally administered with FAE (200,400, and 800 mg/kg/day, respectively). Group 6 was treated with 150 mg/kg of metformin. At the end of week 4, the rats were anesthetized and then sacrificed by cardiac puncture. Then, the levels of liver markers, malondialdehyde (MDA), and antioxidant enzymes capacity were evaluated in each group. Results: Treatment with FAE resulted in a significant reduction in aspartate transaminase (AST) and alanine transaminase (ALT) activities as well as in the serum and liver tissue contents of MDA in comparison to the diabetic control group (P<0.001). The FAE-treated diabetic rats showed a significant increase in catalase, glutathione peroxidase (GPx), and super oxide dismutase (SOD) activities of the liver (P-values were dose-dependent). Furthermore, the extract has an ameliorative effect on the histopathological changes of the liver in alloxan induced diabetes. Conclusions: These findings suggest that FAE can reduce the complications of diabetes, prevent oxidative stress, and improve antioxidant status in diabetic rats.
INTRODUCTION
Diabetes Mellitus (DM), a major worldwide health problem, is a chronic metabolic disease that is characterized by increased concentration of glucose in the blood, resulting from the defects in insulin secretion, insulin action, or both [1, 2] . It has been found that diabetes-induced hyperglycemia can cause various structural and metabolic problems in many body organs such as kidney, muscle, nerve, etc. [3] .
One of the major complications of diabetes is its effect on the liver and hepatocytes [4, 5] . In liver, diabetes can lead to glycogen deposition, steatosis and nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis, biliary disease, cholelithiasis, cholecystitis, and other related complications [6] . There has been extensive research regarding the liver disease occurring as a consequence of diabetes mellitus. For example, Wild et al. showed that type 2 DM is related to the increased risk associated with different types of liver diseases [7] and Hazlehurst et al. demonstrated that non-alcoholic fatty liver disease (NAFLD) is prevalent among up to 70% of the patients with diabetes [8] . Several experimental studies suggest that increased production of reactive oxygen species (ROS) in diabetes plays an important role in the onset of hyperglycemia-related liver damage [9] . However, antidiabetic medications are now used for the treatment of diabetic patients many of which are incapable of treating the complications caused by diabetes such as liver disease. Furthermore, due to the serious adverse effects of synthetic drugs, using these medications for long periods of time has now been limited [10] . Therefore, medicinal plants which have traditionally been used for herbal remedies are now used for the treatment of many diseases and illnesses.
Ferulago angulata (Schlecht) Boiss., belongs to the Apiaceae, is a medicinal plant of West Asia, which contains essential oils and has many therapeutic uses in traditional medicine [11] . The phenolic and flavonoids compounds of Ferulago angulata extract (FAE) exhibit antioxidant, antimicrobial and anti-cancer properties [12, 13] . The lipid-lowering effects and lipid peroxidationdecreasing properties of this plant have been shown [10] .
In the previous study, we showed the beneficial effects of FAE on lipid profile and blood sugar [14] . However, we could not find any studies on the hepatoprotective and antioxidants effects of FAE in experimental diabetes mellitus. Therefore, in the present study, we aimed to evaluate the liver enzymes and antioxidant effects of FAE in alloxan-induced diabetic rats.
MATERIALS AND METHODS

Animals
Healthy adult male Wistar albino rats with an average weight of 200-250 g were purchased from Pasture Institute, Tehran, Iran and housed in standard and clean cages (2 per cage) under controlled environmental conditions at room temperature of 22 ± 3°C and in a 12:12 lightdark cycle with free access to a standard rat chow and clean water [5] . The animal experiments ethics committee approved the study (Approval number IR.ARUMS.REC.1394.129).
Diabetes Induction
Diabetes was induced in rats by the intraperitoneal (i.p.) injection of fresh solution of alloxan monohydrate (Sigma Ltd., USA) (120 mg/kg) for 3 days [15] . Elevated glucose level (>300 mg/dl) in the blood from the tail vein (OKmeter Match, Taiwan) on days 3 and 7 after the injection of alloxan was taken as the confirmation of diabetes [16] . Normal rats were injected with an equal volume of vehicle (sodium citrate buffer).
Preparation of Plant Extract
The plant samples were collected at the humidity level of 45-60% in May and June from Shahr-e Kord, the capital of Chaharmahal and Bakhtiari Province, Iran. The whole plant of FAE was shade-dried at room temperature and powdered in a Wiley mill. Fifty grams of powdered herb was solved in 200 ml of equal volume (1:1) of water and methanol for 72 hours at 15°C to 20°C. The extract was filtered and placed in a vacuumed rotary evaporator solvent [17] . Then, it was incubated at the temperature of 40°C for 2 days. The lyophilized powder was stored in a dry and cold place. Then, appropriate amounts of the lyophilized extract were weighed and orally gavaged to each rat according to their weekly body weights for 4 weeks on a daily basis.
Experimental Groups and Treatment
Control and diabetic animals were divided into 6 groups of at least 9 animals each and treated by an appropriate regimen for 4 weeks as follows: Rats in group I and II received normal rat regimen. Groups III-V treated with 200, 400, and 800 mg/kg hydroalcoholic extract of FAE respectively. In group VI, the standard antihyperglycemic drug (metformin) was administered once daily through oral gavage for 28 consecutive days.
After the last treatment, rats were fasted for 12 h and then anesthetized with chloroform. Blood samples were taken from all the experimental animals by heart puncture and the collected samples were allowed to clot for 30 min and centrifuged at 3000 RPM for 10 min to obtain serum in order to estimate the biochemical parameters. Slices of livers obtained from each animal were washed with isotonic saline solution and homogenized. Then, aliquots were immediately frozen in liquid nitrogen and stored at −80°C until the measurement of parameters such as catalase, superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, and malondialdehyde (MDA) concentration.
Phytochemical Screening
The hydroalcoholic extract of FAE was analyzed for the presence of phenolic compounds and total flavonoids. Phenolic compounds was quantified using Folin-Ciocalteau's assay [18] with some differences. The assay mixture was made with 100 µl of sample, 0.5 ml of 10% FolinCiocalteau's reagent, and 0.4 ml of sodium bicarbonate 7.5% solution. Gallic acid was used as the standard in the concentrations of 0.25, 50, 75, 100, and 125 PPM in methanol 60% solution. The absorbance was measured spectrophotometrically against a blank at 725 nm after the incubation of assay mixture for 30 min.
Total flavonoids measurement of flavonoid concentration in hydroalcoholic extract of FAE was done based on the method described by Dowd using the aluminum chloride colorimetric protocol [19] . A 0.5 ml extract was mixed with methanol (1.5 ml), to which 2% aluminum chloride (1 ml), 5% potassium acetate (6 ml), and deionized water (2.8 ml) were added. The solution was vortexed and allowed to sit for 40 minutes at room temperature. After that, the absorbance was measured at 415 nm using a spectrophotometer. The total flavonoid content was quantified according to the standard curve prepared with gallic acid and the concentrations of flavonoids were reported as mg per gram of extract.
Determination of Biochemical Parameters
The liver biomarkers (AST and ALT) were analyzed using an auto-analyzer (BT 3000, Italy) by commercially available kits from Pars Azmoon (Pars Azmoon Inc., Tehran, Iran).
Determination of Lipid Peroxides in
Plasma and Liver MDA (as a lipid peroxidation marker) level in serum and liver homogenate was measured as described previously by Agarwal et al. [20] using a reverse phase high-pressure liquid chromatography (HPLC) (Agilent 1100 Series HPLC system) after derivatization with 2, 4-dinitrophenylhydrazine were purchased from Merck, Germany.
Assay of Catalase
Catalase was assayed according to the method described previously by Hugo Aebi [21] . The assessment was done spectrophotometrically following the decrease in absorbance at 240 nm. 1 g of the liver tissue was homogenized in 50 mM phosphate buffer (pH 7.0) at the temperature of 4°C and then centrifuged at 4500 RPM. The reaction mixture contained 0.01 M phosphate buffer (pH 7.0), 2 mM Hydrogen peroxide (Merck, Germany), and the enzyme extract. The specific activity of catalase was expressed in terms of unit/mg protein.
Assay of Superoxide Dismutase (SOD)
The specific activity of superoxide dismutase in liver homogenate was determined by the method proposed by Sun et al. [22] . The principle of the method is based on the inhibition of nitroblue tetrazolium (NBT) (Sigma) reduction by the xanthine/XO system as a superoxide generator. In so doing, 250 mg of tissue was homogenized in 4 ml Tris buffer (50 mM Tris, 225 mM sucrose, 1 mM EDTA, PH=74) 0.8 ml of assay reagent (containing 0.3 mM xanthine, 0.6 mM Na 2 EDTA (All chemical were purchased from Merck), 0.15 mM nitroblue tetrazolium (NBT), and 0.4 M (Na 2 CO 3 ) (Merck,) was mixed with 100 µl of liver homogenate and 100 µl Xanthine oxidase. Spectrophotometric absorbance was measured at 560 nm. Activity was expressed as unit/mg protein.
Assay of Glutathione Peroxidase (GPx)
To assay the GPx, 250 mg of tissue was homogenized in 4 ml Tris buffer (50 mM Tris, 225 mM sucrose, 1 mM EDTA, PH=74). 100 µl of tissue homogenate was mixed with 750 µl assay buffer (171 mM potassium phosphate buffer, 4.28 mM sodium azide, 2.14 mM EDTA, 6 mM reduced glutathione, and 0.9 mM NADPH) and 5 µl of glutathione reductase 2 U/mL. The reaction started with the addition of 150 µl of 0.72 mM H2O2. The absorbance was measured by spectrophotometer at 340 nm [23] .
Histomorphological Studies
Some pieces of liver tissue were fixed in 40 g/L buffered formaldehyde, dehydrated with alcohol, embedded in paraffin, cut into 4-5 µm thick sections, and stained with hematoxylin and eosin (H&E) for general histopathological examinations according to a described procedure [24].
Statistical Analysis
Data were analyzed statistically using SPSS Software, Version 20 and the results were expressed as mean ± SEM. One-way analysis of variance (ANOVA) was used to compare different groups and determine overall effect of each treatment with the confidence level of 95% (p<0.05) considered to be significant.
RESULTS
Body Weight
No significant differences were observed in the weight of the healthy and diabetic control animals after 28 days. Furthermore, no significant difference was observed after treatment with FAE or metformin as compared to the diabetic control group.
Blood Glucose
As showed in the previous study [14] , there was a significant increase in blood glucose (P< 0.001) in diabetic rats as compared with those in normal control group. Administration of FAE extract at 200 mg, 400 mg, 800 mg, and metformin decreased blood glucose in diabetic rats by 26% (P<0.01), 59.3% (P<0.001), 69.4% (P<0.001), and 28.8% (P<0.01), respectively.
Toxicity Study
A toxicity study revealed the non-toxic characteristics of the extract. The rats treated with different doses of FAE did not show any drug-induced physical symptoms of toxicity during the whole experimental period and no deaths were reported.
Liver Enzymes
Induction of diabetes caused a significant increase (p< 0.001) in the activities of AST and ALT as compared to the corresponding control animals. Serum activities of AST of diabetic rats significantly decreased (P<0.01 for FAE (200 mg) and P<0.001 for both FAE (400 mg) and FAE (800 mg) after 28 days of treatment. Administration of FAE with the doses of 400 mg and 800 mg significantly decreased ALT activity (P<0.05 and P<0.01, respectively) as compared to the un-treated diabetic group (Table 1) . Treatment with metformin (150 mg/kg) did not show significant decrease in the activity of AST and ALT compared to the diabetic control group. 
Antioxidant Enzymes
As presented in Table 2 , there is a significant decrease in the level of catalase (P<0.01), SOD, and GPx (P<0.001 for both) in the diabetic group compared with the healthy group. Administration of FAE (400 mg) increased catalase, SOD, and GPx significantly (P<0.01 for catalase and CAT and P<0.001 for GPx). Treating with FAE (800 mg) also increased these three enzymes significantly by P<0.001. Treatment with metformin did not change catalase, however it increased SOD and GPx activity (P<0.01).
Oxidative Stress Marker
Concentrations of serum MDA (s-MDA) and tissue MDA (t-MDA) increased in alloxan-induced diabetic rats compared with the healthy control group. Administration of FAE extract for 28 days decreased s-MDA (P<0.001) and t-MDA (P<0.01) significantly as compared with the diabetic control group. Also, in the group treated with metformin, s-MDA and t-MDA decreased significantly (P<0.05 and P<0.01, respectively ( Table 2 ).
Antioxidant Compounds in Extract
The amounts of total phenol, flavonoid, and flavonol were 13, 42, and 4 mg in one gram of hydroalcoholic extract of FAE, respectively.
Liver Histology
The central vein, hepatocyte, and portal space were observed to be normal in the normal control group (Fig. 1-A) . The damage to the liver cells in the form of damaged central vein, hepatocytes, and portal trial could be seen clearly in the alloxan-induced diabetic rats ( Fig. 1-B) . These damages were reversed in the FAE treated groups (Fig. 1-C, D , and E). It seems that the amelioration effect of FAE on liver cells is dosedependent. The therapeutic effect of metformin is shown in (Fig. 1-F) .
DISCUSSION
There are numerous studies and clinical evidences showing that the production of high levels of oxygen free radicals increases in Type 1 diabetes and that the onset of diabetes is closely related to the level of oxidative stress [25, 26] . The diabetogenic substance of alloxan monohydrate has three different pathological effects that intervene in the physiological function of pancreatic beta cells. First, alloxan selectively inhibits glucose-induced insulin secretion through its capability to specifically inhibit glucokinase, the glucose sensor of the beta cell. Second, alloxan is a urea derivative which causes a state of insulin-dependent diabetes mellitus through its ability to induce a selective necrosis of the beta cells. Third, alloxan-induced beta-cell toxicity is mediated by the formation of oxygen free radicals such as superoxide. These three effects of alloxan can be assigned to its specific chemical properties that cause islet beta cell destruction and increase plasma glucose [27-29]. Injury to the liver in diabetes, which can be induced by alloxan, releases and also increases the level of liver enzymes in the bloodstream [30] . The significant dose-dependent reduction in the serum levels of these enzymes after the administration of FAE indicates its antihepatotoxic effect in diabetes which may have been brought about by the stability of plasma membrane as well as the repair of tissue damage.
The results of our study indicated that the plant extract administered to the diabetic animals during 28 days reduced liver and serum MDA concentrations (P<0.001). It has been revealed that in hyperglycemia, antioxidant defenses change due to the presence of diabetic conditions leading to the increase in free radical production [31, 32] . FAE significantly inhibited the increase of serum and liver MDA levels and indicated a protective effect against oxidative stress.
Antioxidant scavenger systems deficiency under diabetic conditions can increase lipid peroxidation due to oxidative stress [33, 34] . The results of our study showed that catalase, SOD, and GPx activities were significantly lower in the diabetic animals compared to the healthy ones (P<0.01 for catalase and P<0.001 for two others). After 28 days, treatment with FAE significantly increased the activity of these enzymes (P values were dose dependent and was not significant in FAE 200 mg/kg). These effects might be related to the antioxidant activity of the extract. The increase in the activity of enzymatic antioxidants may be helpful in reversing the action of the alloxan monohydrate through the antioxidant mechanism [35] .
In this study, we observed some lesions in the livers of diabetic animals including structural changes in hepatocytes, both sinusoids and portal areas, and enlargement of sinusoids. The same results were reported by Mahmoud and AlSalahy who demonstrated in their study that alloxan-induced hyperglycemia plays a crucial role in the genesis of liver injury [36] . The structural abnormalities and degenerative changes induced by alloxan monohydrate in the livers of diabetic rats ameliorated by the administration of FAE and metformin. This effect was more prominent at the dose of 800 mg/kg FAE. The presence of phenolic compounds and flavonoids in our extract might be the reason for its antioxidant and thus liver treating activity [37].
CONCLUSION
The present investigation suggested that hydroalcoholic extract of FAE exerts an antihepatotoxic effect via inhibiting oxidative stress due to the presence of phenolic and flavonoid compounds and their anti-oxidant nature. However, further investigations are needed to elucidate the precise molecular mechanism of specific bio-active agents of FAE for the protection against, and treatment of, the diabetes induced by alloxan or other toxic agents and validate these findings.
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